Document Classification

Section Type: RESULTS

Text: Both groups experienced a significant reduction in HbA (1c) (A1C) level (rosiglitazone : 7. 9 + / - 1. 3 to 6. 9 + / - 0. 7 %, P < 0. 0001 ; placebo : 7. 7 + / - 0. 8 to 7. 0 + / - 0. 9 %, P = 0. 002) and a significant increase in weight (rosiglitazone : 97. 2 + / - 11. 8 to 100. 6 + / - 16. 0 kg, P = 0. 008 ; placebo : 96. 4 + / - 12. 2 to 99. 1 + / - 15. 0, P = 0. 016).